27
views
0
recommends
+1 Recommend
0 collections
    9
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Camptothecin and taxol: discovery to clinic--thirteenth Bruce F. Cain Memorial Award Lecture.

      Cancer research
      Animals, Awards and Prizes, Camptothecin, chemistry, history, therapeutic use, Chemistry, Physical, Clinical Trials as Topic, Drug Screening Assays, Antitumor, History, 20th Century, Humans, Medical Oncology, Neoplasms, drug therapy, Neoplasms, Experimental, Paclitaxel, Societies, Medical, United States

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Camptothecin and taxol are secondary metabolites found, respectively, in the wood bark of Camptotheca acuminata, a native of China, and Taxus brevifolia, found in the northwest Pacific coastal region of the United States. The compounds were isolated guided by bioassay on various extracts and chromatographic fractions. Their unique and hitherto unknown structures were elucidated by nuclear magnetic resonance, mass spectrometry, and X-ray analysis. Both compounds have unique mechanisms of antitumor activity; camptothecin uniquely inhibits an enzyme, topoisomerase I, involved in DNA replication. Taxol binds to a protein, tubulin, thus inhibiting cell division. Taxol has been called the best new anticancer agent developed from natural products, showing particular efficacy against ovarian cancer. Camptothecin and analogues singly or combined with cisplatin show efficacy against solid tumors, breast, lung, and colorectal, which hitherto have been unaffected by most cancer chemotherapeutic agents.

          Related collections

          Author and article information

          Comments

          Comment on this article